【24h】

How 217 Pediatric Intensivists Manage Anemia at PICU Discharge: Online Responses to an International Survey*

机译:217名儿科强度分子在PICU院校管理贫血:对国际调查的在线回应*

获取原文
获取原文并翻译 | 示例
           

摘要

Supplemental Digital Content is available in the text. Objective: To describe the management of anemia at PICU discharge by pediatric intensivists. Design: Self-administered, online, scenario-based survey. Setting: PICUs in Australia/New Zealand, Europe, and North America. Subjects: Pediatric intensivists. Interventions: None. Measurements and Main Results: Respondents were asked to report their decisions regarding RBC transfusions, iron, and erythropoietin prescription to children ready to be discharged from PICU, who had been admitted for hemorrhagic shock, cardiac surgery, craniofacial surgery, and polytrauma. Clinical and biological variables were altered separately in order to assess their effect on the management of anemia. Two-hundred seventeen responses were analyzed. They reported that the mean (± sem ) transfusion threshold was a hemoglobin level of 6.9?±?0.09?g/dL after hemorrhagic shock, 7.6?±?0.10?g/dL after cardiac surgery, 7.0?±?0.10?g/dL after craniofacial surgery, and 7.0?±?0.10?g/dL after polytrauma ( p < 0.001). The most important increase in transfusion threshold was observed in the presence of a cyanotic heart disease (mean increase ranging from 1.80 to 2.30?g/dL when compared with baseline scenario) or left ventricular dysfunction (mean increase, 1.41–2.15?g/dL). One third of respondents stated that they would not prescribe iron at PICU discharge, regardless of the hemoglobin level or the baseline scenario. Most respondents (69.4–75.0%, depending on the scenario) did not prescribe erythropoietin. Conclusions: Pediatric intensivists state that they use restrictive transfusion strategies at PICU discharge similar to those they use during the acute phase of critical illness. Supplemental iron is less frequently prescribed than RBCs, and prescription of erythropoietin is uncommon. Optimal management of post-PICU anemia is currently unknown. Further studies are required to highlight the consequences of this anemia and to determine appropriate management.
机译:文本中提供了补充数字内容。目的:描述儿科强度分子PICU放电贫血的管理。设计:自适应,在线,基于场景的调查。环境:澳大利亚/新西兰,欧洲和北美的皮比。主题:儿科强度。干预措施:没有。测量和主要结果:受访者被要求报告其有关RBC输血,铁和促红细胞生成素处方的决定,以便从PICU中解雇的儿童,他们被录取为出血性休克,心脏手术,颅面外科和PolyTrauma。临床和生物变量分别改变,以评估它们对贫血的管理的影响。分析了两百十七次反应。他们报道了平均值(±SEM)输血阈值是6.9?±0.09?g / dl的血红蛋白水平,7.6?±0.10?k / dl后心脏手术,7.0?±0.10?g / DL颅面外科和7.0?±0.10?G / DL在Polytrauma(P <0.001)后。在紫绀心脏病的存在下观察到输血阈值的最重要增加(与基线场景相比,从1.80至2.30〜2.30?G / DL的平均值增加)或左心室功能障碍(平均增加,1.41-2.15?G / DL )。三分之一的受访者表示,无论血红蛋白水平还是基线情景,它们都不会在PICU放电中规定铁。大多数受访者(69.4-75.0%,取决于场景)没有规定促红细胞生成素。结论:儿科强度主义者说明他们在PICU放电时使用限制性输血策略,类似于他们在临界疾病的急性期间使用的那些。补充铁比RBC较少,促红细胞生成素的处方罕见。 PICU贫血后的最佳管理目前未知。需要进一步的研究来突出这种贫血的后果并确定适当的管理。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号